Quantitative Bioanalysis of Antibody-Drug Conjugates by Mass Spectrometry, Upcoming Webinar Hosted by Xtalks
TORONTO, Oct. 24, 2023 /PRNewswire-PRWeb/ -- Discover a groundbreaking webinar delving into bioanalytical complexity, strategy and regulatory considerations when developing ADC therapeutics with a focus on developing and validating liquid chromatography-mass spectrometry (LC-MS) pharmacokinetics (PK) assays.
- In this free webinar, gain insights into the complexity, comprehensive strategy and regulatory considerations for bioanalysis in support of the development of drug-conjugated antibody (ADC).
- Attendees will learn bioanalytical strategies for ADC drug development and how to apply the PK assay results to inform on ADC stability and dose selection.
- Antibody-drug conjugates are a new and fast-growing class of targeted drugs consisting of "antibodies, cytotoxic drugs and linkers".
- Join experts from Amador Bioscience , Meina Liang, Chief Technology Officer (CTO), President of Bioanalysis & Biomarkers; and Andrea Ngai, Associate Director, Bioanalysis & Biomarkers, for the live webinar on Wednesday, November 8, 2023, at 12pm EST (9am PST).